Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02408005

Ligand	Ligand name	Chain	PDB	Tanimoto
AS4	ALDOSTERONE	A	2AA2	0.73
AS4	ALDOSTERONE	A	2Q1H	0.73
C3S	CHOLEST-5-EN-3-YL HYDROGEN SULFATE	A	1S0X	0.75
C3S	CHOLEST-5-EN-3-YL HYDROGEN SULFATE	A	2Q9F	0.75
C3S	CHOLEST-5-EN-3-YL HYDROGEN SULFATE	A,B,C	2HKA	0.75
DTX	DIGITOXIGENIN	A	1LNM	0.76
S5H	5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE	L	2DBL	0.72
ZK5	9ALPHA-FLUOROCORTISOL	A	1GS4	0.71
1CA	DESOXYCORTICOSTERONE	A,B	1Y9R	0.72
1CA	DESOXYCORTICOSTERONE	A,B,C	2ABI	0.72
1CA	DESOXYCORTICOSTERONE	A	2Q3Y	0.72
1CA	DESOXYCORTICOSTERONE	A	2AA7	0.72
HCR	7-HYDROXYCHOLESTEROL	A	1ZHT	0.76
MOU		A,B	2NPF	0.72
VDY	3-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANOL	A,B	1J78	0.72
VDY	3-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANOL	A,D	1MZ9	0.72
CLL	CHOLESTERYL LINOLEATE	A,B	1CLE	0.82
GR4		H,I	1AWF	0.77
KH1	5-(2-{1-[1-(4-ETHYL-4-HYDROXY-HEXYLOXY)-ETHYL]-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE}-ETHYLIDENE)-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1IE8	0.74
O1C	2ALPHA-(3-HYDROXYPROPYL)-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HB7	0.71
DOG	DIGOXIGENIN	A	1LKE	0.76
CBO	CARBENOXOLONE	A,B,C,D	1HDC	0.78
CBO	CARBENOXOLONE	A,B,C,D	2BEL	0.78
CLR	CHOLESTEROL	A,B	2ZXE	0.78
CLR	CHOLESTEROL	A	1N83	0.78
CLR	CHOLESTEROL	A	2RH1	0.78
CLR	CHOLESTEROL	A	1LRI	0.78
CLR	CHOLESTEROL	A	1ZHY	0.78
CLR	CHOLESTEROL	A	3D4S	0.78
JB1	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,3S)-3-(2-hydroxyethyl)heptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol	A	2ZXM	0.7
COV	(1S,3R,5Z,7E,14beta,17alpha)-17-[(2S,4S)-4-(2-hydroxy-2-methylpropyl)-2-methyltetrahydrofuran-2-yl]-9,10-secoandrosta-5,7,10-triene-1,3-diol	A	3CS4	0.73
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	A,D	1R1K	0.76
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	E,U	1Z5X	0.76
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	E,F,G,H	2NXX	0.76
2OB	CHOLESTERYL OLEATE	A	2OBD	0.82
803	LOVASTATIN	A,B	1CQP	0.7
LVA	(3R,5R)-7-((1R,2R,6S,8R,8AS)-2,6-DIMETHYL-8-{[(2R)-2-METHYLBUTANOYL]OXY}-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL)-3,5-DIHYDROXYHEPTANOIC ACID	A,B	1T02	0.7
114	COMPACTIN	A,B,C,D	1HW8	0.7
OCC	2ALPHA-(3-HYDROXYPROPOXY)-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HAR	0.74
PLO	(3BETA)-3-HYDROXYPREGN-5-EN-20-ONE	A	1Q20	0.8
TES	TESTOSTERONE	A	1JTV	0.75
TES	TESTOSTERONE	A	2Q7L	0.75
TES	TESTOSTERONE	A	2Q7I	0.75
TES	TESTOSTERONE	A,B	1J96	0.75
TES	TESTOSTERONE	A	2Q7K	0.75
TES	TESTOSTERONE	A,B	1Q13	0.75
TES	TESTOSTERONE	H	1I9J	0.75
TES	TESTOSTERONE	A,B	1AFS	0.75
TES	TESTOSTERONE	H	1VPO	0.75
TES	TESTOSTERONE	A	2Q7J	0.75
TES	TESTOSTERONE	A,B	3BUR	0.75
TES	TESTOSTERONE	A	2AM9	0.75
SIM	SIMVASTATIN	A,B,C,D	1HW9	0.72
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EAU	0.71
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EB3	0.71
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EB4	0.71
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A,B	2AAX	0.71
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	1H61	0.71
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A,B	3CMF	0.71
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	2Q1V	0.71
NTH	SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER	A,B	1BUQ	0.86
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A,B	1E3R	0.79
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	3DHE	0.79
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1J99	0.79
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1COY	0.79
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1Q22	0.79
HC2	20-HYDROXYCHOLESTEROL	A	1ZHW	0.78
FUA	FUSIDIC ACID	A	1QCA	0.79
FUA	FUSIDIC ACID	A,B,C,D,E,F,G,H,I,J,K,L	1Q23	0.79
FUA	FUSIDIC ACID	A,B	2VUF	0.79
0MA	maslinic acid	A	2QN2	0.76
OBN	OUABAIN	H,L	1IBG	0.72
CO1	17-[3-(3,3-DIMETHYL-OXIRANYL)-1-METHYL-PROPYL]-10,13-DIMETHYL-2,3,4,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-3-OL	A,B	1P8D	0.78
HC3	25-HYDROXYCHOLESTEROL	A	1ZHX	0.78
GR3	3-ACETOXY-17-(1-FORMYL-5-METHYL-3-OXO-HEX-4-ENYL)-16-HYDROXY-4,10,13,14-TETRAMETHYL-2,3,4,5,6,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-4-CARBOXYLIC ACID	B,D	1AWH	0.79
C3O	2ALPHA-PROPOXY-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HAS	0.74
VD2	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYL-CYCLOHEXANE-1,3-DIOL	A	1RKH	0.71
LAN	LANOSTEROL	A	1W6K	0.72
C0R	CORTICOSTERONE	A	2A3I	0.73
C0R	CORTICOSTERONE	A,B	1Y5R	0.73
ERG	ERGOSTEROL	A	1BXM	0.75
ERG	ERGOSTEROL	A	1ZHZ	0.75
ERG	ERGOSTEROL	A,B	2AIB	0.75
0AS	asiatic acid	A	2QN1	0.76
ZBA	12,13-Epoxytrichothec-9-ene-3,4,8,15-tetrol-4,15-diacetate-8-isovalerate	A	2RKV	0.75
ZBA	12,13-Epoxytrichothec-9-ene-3,4,8,15-tetrol-4,15-diacetate-8-isovalerate	A,B,C,D	2ZBA	0.75
TH2	TESTOSTERONE HEMISUCCINATE	A,B	2CBT	0.87
TH2	TESTOSTERONE HEMISUCCINATE	A,B,C,D,E,F	2CBQ	0.87
TH2	TESTOSTERONE HEMISUCCINATE	A	2CBO	0.87
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPG	0.75
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPJ	0.75
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPF	0.75
JC1	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2S,3S)-3-(2-hydroxyethyl)heptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol	A	2ZXN	0.7
DL7	(5beta,14beta,17alpha,25R)-3-oxocholest-7-en-26-oic acid	A	3GYU	0.78
DL4	(14beta,17alpha,25R)-3-oxocholest-4-en-26-oic acid	A	3GYT	0.76
0CO	(1S,3R,5Z,7E,14beta,17alpha,23R)-23-(2-hydroxy-2-methylpropyl)-20,24-epoxy-9,10-secochola-5,7,10-triene-1,3-diol	A	3CS6	0.73
CBW	(3BETA,5BETA,14BETA)-3-HYDROXY-11-OXOOLEAN-12-EN-29-OIC ACID	A	2W4Q	0.73
SOD		A	2E1R	0.7
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A,B	2VDY	0.72
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A	2V95	0.72
20E	(2beta,3beta,5beta,22R)-2,3,14,20,22,25-hexahydroxycholest-7-en-6-one	A,D	2R40	0.76
SIH	PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE	H	1DBM	0.85